Logos Global Management LP Keros Therapeutics, Inc. Put Options Transaction History
Logos Global Management LP
- $513 Million
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding KROS
# of Institutions
178Shares Held
38.8MCall Options Held
938KPut Options Held
1.39M-
Nuveen, LLC Charlotte, NC3.95MShares$57.5 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY2.6MShares$37.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.57MShares$37.4 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.51MShares$36.6 Million0.0% of portfolio
-
Morgan Stanley New York, NY1.7MShares$24.7 Million0.0% of portfolio
About Keros Therapeutics, Inc.
- Ticker KROS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,757,000
- Market Cap $375M
- Description
- Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...